Rapid establishment and/or termination of substantial steady-state drug delivery

Details for Australian Patent Application No. 2010298733 (hide)

Owner Intarcia Therapeutics, Inc.

Inventors Alessi, Thomas R.; Luskey, Kenneth L.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010298733

PCT Pub. Number WO2011/037623

Priority 61/358,112 24.06.10 US; 61/277,724 28.09.09 US

Filing date 21 September 2010

Wipo publication date 31 March 2011

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C40B 30/04 (2006.01) Methods of screening libraries - by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding

Event Publications

5 April 2012 PCT application entered the National Phase

  PCT publication WO2011/037623 Priority application(s): WO2011/037623

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010298756-A fitting arrangement for a door handle

2010298725-Chemical production module and dose synthesis card for pet biomarker production system